ct

Lonza Licenses Gene Expression to Kyowa Hakko

October 27, 2008 | Contact Author | By: Katie Schaefer
Close
Fill out my online form.
  • Article
  • Keywords/Abstract

Abstract: Lonza and Kyowa Hakko Kogyo Co., Ltd. have signed an agreement where Lonza will license its GS Gene Expression System (GS: glutamine synthetase) to Kyowa Hakko and its US subsidiary BioWa Inc.

Lonza and Kyowa Hakko Kogyo Co., Ltd. have signed an agreement  where Lonza will license its GS Gene Expression System (GS: glutamine synthetase) to Kyowa Hakko and its US subsidiary BioWa Inc. (Kyowa Hakko Group). Prior to this agreement BioWa and Lonza entered into a strategic research collaboration agreement combining Kyowa Hakko’s POTELLIGENT technology with Lonza’s GS Gene Expression System.

This worldwide, non-exclusive umbrella research and license agreement enables Kyowa Hakko Group to use Lonza’s proprietary GS-System and the POTELLIGENT technology as a platform for the production of antibodies and recombinant proteins being developed by Kyowa Hakko Group. For more information, visit www.lonza.com.